Kinney Drugs makes history with first sale of over-the-counter birth control pill

On Monday, March 18, 2024, Kinney Drugs in Potsdam, NY, made history by completing the first U.S. sale of Opill®, the first FDA-approved over-the-counter birth control pill. This landmark sale marks a significant step in making daily oral contraceptives more accessible to women across the United States. Opill® is known for its convenience, not requiring a prescription, and its effectiveness at preventing pregnancy when used as directed.

Opill® is unique among oral contraceptives as it is a progestin-only pill, free from estrogen, making it a crucial option for many women who face barriers in accessing contraceptives. The availability of Opill® over the counter at Kinney Drugs addresses common challenges such as prescription requirements and the inconvenience of securing a healthcare provider’s appointment.

Katie Niles, PharmD, R.Ph., Vice President of Merchandising & Marketing at Kinney Drugs, emphasized the pharmacy’s commitment to increasing access to safe and effective birth control options. This move by Kinney Drugs reflects a broader shift towards improving healthcare accessibility and empowering women to take control of their reproductive health without unnecessary hurdles.